The British pharmaceutical company AstraZeneca has admitted, in the framework of a legal claim, that your COVID-19 vaccine could cause the syndrome thrombosis with thrombocytopenia (TTS), a rare side effect that causes blood clots.
This admission was revealed through legal documents presented to the Superior Courtwhich specifies that, although extremely rare, these cases of thrombosis can be caused by the vaccine developed in collaboration with the University of Oxford.
More information
The class action lawsuit, which includes 51 casesalleges that the vaccine has caused serious injuries and even death, requesting financial compensation for those affected. The laboratory, although it has denied the accusations in public, acknowledges in the documents that the exact mechanism by which the vaccine could cause TTS remains unknown and that the causality in each individual case must be determined by expert evidence.
This recognition comes after they identified cases of thrombosis in several countries, including Chilewhere a young man from Puente Alto experienced a case of thrombosis that led health authorities to suspend the use of the vaccine in people under 45 years of age.
ISP received a request to import Oxford and Astrazeneca vaccine
Enlarge
AstraZeneca maintains that TTS can occur even in the absence of vaccination, highlighting the complexity of establishing a direct relationship in individual cases.
AstraZeneca This possible adverse effect had already been referred to in 2021, through a publication in the The Lancet magazine from the study titled “Very rare thrombosis with thrombocytopenia after the second dose of AZD1222: an analysis of the global safety database”, carried out by scientists from the laboratory itself.
AstraZeneca: “the benefits of vaccination outweigh the risks”
The company behind the vaccine stated that they do not comment on ongoing litigation, but expressed that “we extend our deepest solidarity to anyone who has lost a loved one or reported health problems.”
“Patient safety is our top priority and regulatory authorities have clear and strict standards to ensure the safe use of all medicines, including vaccines. Based on the body of evidence from clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continually been shown to have an acceptable safety profile and regulators consistently affirm that the benefits of vaccination outweigh the risks of potential side effects. extremely rare,” they added.
Finally, they assured that “Drug regulators around the world have confirmed that the benefits of vaccination outweigh the risks of extremely rare adverse effects. According to independent estimates, more than 6.5 billion lives were saved worldwide in the first year of use of the vaccine and more than three billion doses were supplied worldwide, positively impacting the control and management of the pandemic. .
